XYOSTED: payments to doctors
Payments that named XYOSTED as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $3.1M
- Providers
- 23,335
- Transactions
- 111,260
- Average per transaction
- $27
The per-transaction average — $27 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 23,335 providers the average total is $131, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Antares Pharma, Inc. | $2,778,404 | 90.9% |
| Supernus Pharmaceuticals, Inc. | $277,375 | 9.1% |